KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Operating Expenses (2016 - 2025)

Bausch Health Companies' Operating Expenses history spans 17 years, with the latest figure at $2.3 billion for Q4 2025.

  • For Q4 2025, Operating Expenses rose 16.04% year-over-year to $2.3 billion; the TTM value through Dec 2025 reached $8.5 billion, up 4.63%, while the annual FY2025 figure was $8.5 billion, 4.63% up from the prior year.
  • Operating Expenses for Q4 2025 was $2.3 billion at Bausch Health Companies, up from $2.1 billion in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.4 billion in Q4 2022 and bottomed at $1.5 billion in Q3 2021.
  • The 5-year median for Operating Expenses is $2.0 billion (2024), against an average of $2.0 billion.
  • The largest annual shift saw Operating Expenses soared 40.15% in 2021 before it fell 27.36% in 2022.
  • A 5-year view of Operating Expenses shows it stood at $1.8 billion in 2021, then surged by 32.8% to $2.4 billion in 2022, then dropped by 15.77% to $2.0 billion in 2023, then decreased by 2.2% to $2.0 billion in 2024, then rose by 16.04% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Operating Expenses are $2.3 billion (Q4 2025), $2.1 billion (Q3 2025), and $2.1 billion (Q2 2025).